Hyderabad, the new vaccine capital of India
Apart from Covaxin and Sputnik V, companies based in the city are also involved in developing or manufacturing several other Covid-19 vaccines.
bharat biotech vaccine
January 2021
Covid-19 vaccine: The accessibility challenge
While the government rolled out the Covid-19 vaccination programme on January 16, questions of accessibility and affordability remain for sections of the population.
Here’s how India prepared to roll out the vaccine
The massive campaign to deploy the Covid-19 vaccine rests on infrastructure, both physical and digital. Using past campaigns, India put together a multi-pronged strategy for a smooth roll-out.
Bharat Biotech’s perception battle
For BBIL’s founder Krishna Ella, the roll-out of a made-in-India vaccine, Covaxin, is peppered with challenges. Two recent deals with Brazilian and American firms have now buoyed him.
